BIO-Europe® 2016- Value and the pricing of innovation

November 7, 2016
Balancing the cost of innovation and ensuring access to high-quality, effective medical treatment continues to be a challenge for all modern healthcare systems. Significant shifts in global and local market dynamics, policy and politics are prompting a discussion about other dimensions of value, be they economic, social, or scientific. How can biotech innovators best demonstrate the value of their therapies so that outcomes are measurable and relevant to all stakeholders?
Previous Article
BIO-Europe® 2016 recap from day one
BIO-Europe® 2016 recap from day one

It was the best of times, it was the worst of times. This was the biotech industry in 2016. While this year...

Next Article
Steps for choosing the right development partner
Steps for choosing the right development partner

Guest post by Laura Marquis, Vice President and Global Head, Emerging Biopharma, QuintilesIMS™ As I prepare...